Ads
related to: who makes rhopressa eye drops for glaucoma- Discover Patient Types
See If Your Patients' Conditions
Qualify Them For Treatment.
- Patient Savings Available
Eligible Patients May Pay As Little
As $25 Copay For A 90-Day Supply.
- Dosing Information
Learn How This Treatment's
Dosing May Help Your Patients.
- Head -To-Head Data
Learn How This Treatment Compares
To Latanoprost For IOP Reduction.
- Discover Patient Types
Search results
Results From The WOW.Com Content Network
Netarsudil, sold under the brand name Rhopressa among others, is a medication for the treatment of glaucoma. [1] [2] [3] In the United States, in December 2017, the Food and Drug Administration (FDA) approved a 0.02% ophthalmic solution for the lowering of elevated intraocular pressure in people with open-angle glaucoma or ocular hypertension.
KEGG. D11558. Netarsudil/latanoprost, sold under the brand name Rocklatan among others, is a fixed-dose combination medication use to treat elevated intraocular pressure (IOP) in people with open-angle glaucoma or ocular hypertension. [1][2] It contains netarsudil mesylate and latanoprost. [1][2] It is applied as eye drops to the eyes. [1][2 ...
Latanoprost, sold under the brand name Xalatan among others, is a medication used to treat increased pressure inside the eye (intraocular pressure). [5] This includes ocular hypertension and open-angle glaucoma. [5] Latanaprost is applied as eye drops to the eyes. [5] Onset of effects is usually within four hours, and they last for up to a day. [5]
Ripasudil's mechanism of action affects intraocular pressure, or IOP, "by directly acting on the trabecular meshwork, thereby increasing conventional outflow through the Schlemm’s canal." [2] More simply, it is an "out-flow" drug that reduces IOP by stimulating the movement of aqueous humour from the ciliary body away from the eye. [3]
Specialty. Ophthalmology. [edit on Wikidata] Glaucoma medication is divided into groups based on chemical structure and pharmacologic action. The goal of currently available glaucoma therapy is to preserve visual function by lowering intraocular pressure (IOP) in patients that have an increased intraocular pressure.
Aerie Pharmaceuticals Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Aerie's two lead product candidates are once-daily therapies for lowering intraocular pressure with mechanisms to treat patients ...
Ads
related to: who makes rhopressa eye drops for glaucoma